Raynham, Mass.-based DePuy Synthes; Dublin, Ireland-based Medtronic; San Diego-based NuVasive; Kalamazoo, Mich.-based Stryker; and Warsaw, Ind.-based Zimmer Biomet dominate the MIS market.
A growing number of spinal disorder cases will spur market growth, as well as the increasing adoption of the MI sacroiliac joint fusion technique. A dearth of skilled surgeons in MIS techniques will pose as an obstacle to market growth, however.
More articles on MIS:
Minimally invasive vs. open spine surgery for spondylolisthesis: 5 things to know
MIS surgeon Dr. Douglas Slaughter joins ranks of NJ Spine & Orthopedic — 5 notes
4 key notes on defensive medicine for spine-focused neurosurgeons — premiums reach $104k
